LIQUIDBX participants include leading companies, medical institutions, and academic institutions.
Israel’s Innovation Authority backed Genome Editing Consortium
The LIQUIDBX consortium is supported with research and development grants from the Innovation Authority of Israel (IAI). The LIQUIDBX consortium operates under the Magnet Consortium track of the IAI.
The support of the Innovation Authority of Israel through the LIQUIDBX consortium enables the member companies to be at the forefront of the liquid biopsy field worldwide while recruiting leading scientists and deploying innovative technologies developed in Israel.
The LIQUIDBX consortium was founded by Yoav Medan, a key figure in Israeli high-tech and a true visionary. Yoav played a critical role in the formation of the LIQUIDBX consortium and laid out its vision. In memory of Yoav, we dedicate the work of the consortium to his legacy.
At LIQUIDBX, we strive to develop groundbreaking technologies that serve as a testament to Yoav’s vision and his contributions to the industry. His impact on Israeli high-tech and his visionary leadership will be greatly missed.
We are proud to continue building upon Yoav’s legacy by pursuing cutting-edge solutions and pushing the boundaries of what is possible. We believe that our work will make a significant impact, and we are committed to honoring Yoav’s memory through our continued innovation and dedication to the field.
Copyright 2023 LIQUIDBX – All Rights Reserved
Produced by Webzilla